Figure 6 Example of a graphical display (frequency by primary SOC) – Figure 7 Example of a graphical display (frequency by primary and secondary SOC) – Figure 8 Example of a tabular display (frequency by primary SOC) – Figure 9a The upper bar of each pair represents numbers of reports from Consumers – (blue) and the lower bar reports from Health Care Professionals (red) (Population 1) Figure 9b The upper bar of each pair represents numbers of reports from Consumers – (blue) and the lower bar reports from Health Care Professionals (red) (Population 2) Figure 10 For a small dataset, a display of PTs may be adequate – SOC Infections and infestations Primary SOC Analysis 25 mg Placebo Adverse Event (MedDRA v19.0) MyDrug (N=15) (N=44) SOC Infections and infestations 14 (31.8%) 4 (26.7%) PT Upper respiratory tract infection 5 2 PT Sinusitis 3 0 PT Urinary tract infection 2 1
Figure 6 – Example of a graphical display (frequency by primary SOC) Figure 7 – Example of a graphical display (frequency by primary and secondary SOC) Figure 8 – Example of a tabular display (frequency by primary SOC) Figure 9a – The upper bar of each pair represents numbers of reports from Consumers (blue) and the lower bar reports from Health Care Professionals (red) (Population 1) Figure 9b – The upper bar of each pair represents numbers of reports from Consumers (blue) and the lower bar reports from Health Care Professionals (red) (Population 2) Figure 10 – For a small dataset, a display of PTs may be adequate SOC Infections and infestations Primary SOC Analysis Adverse Event (MedDRA v19.0) 25 mg MyDrug (N=44) Placebo (N=15) SOC Infections and infestations 14 (31.8%) 4 (26.7%) PT Upper respiratory tract infection 5 2 PT Sinusitis 3 0 PT Urinary tract infection 2 1
9610-1910_datretptc_r3_12_sep2016.docx